The analysis, conducted by researchers from the University of Oxford and supported by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre and the Medical Research Council, revealed that taking the drug, a popular medication for type II diabetes, had no increased risk of adverse neurological or psychiatric outcomes compared to other antidiabetic medications, challenging recent concerns about the drugs safety
For someone researching How much weight can you lose with GLP-1 injections, the better question may be: what kind of progress is realistic for my body, my health history, and my goals
Should I be concerned about muscle loss alongside rapid fluid loss on semaglutide
Discuss any history of thyroid problems, pancreatitis, kidney issues, or gallbladder disease
R., Tabrizi, M., Ghaleiha, A., and Akhondzadeh, S
Melanie Jay, director of the NYU Langone Comprehensive Program on Obesity Research, previously told TODAY.com